Understanding the efficacy variables of an HIV vaccine trial

Lancet Infect Dis. 2012 Jul;12(7):499-500. doi: 10.1016/S1473-3099(12)70117-2. Epub 2012 May 30.
No abstract available

Publication types

  • Comment

MeSH terms

  • AIDS Vaccines / therapeutic use*
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Male
  • Risk-Taking*

Substances

  • AIDS Vaccines
  • AIDSVAX
  • AIDSVAX B-E